Patent · US Active

Bivalent, bispecific binding proteins for prevention or treatment of HIV infection

US11129905B2 · kind B2 · utility

5Cited by

3References

3Claims

0Family size

Assignee

Sanofi · FR

Inventors

Zhi-yong Yang · Potomac, US
Gary J. Nabel · Cambridge, US
Ling Xu · Potomac, US
Jochen BENINGA · Frankfurt am Main, DE
Jochen Kruip · Frankfurt am Main, DE
Ercole Rao · Frankfurt am Main, DE
Wulf-Dirk Leuschner · Frankfurt am Main, DE
Christian Beil · Frankfurt am Main, DE
Christian Lange · Frankfurt am Main, DE

Key dates

Filing date	Oct 21, 2019
Grant date	Sep 28, 2021
Priority date	—
Expiry date	Oct 21, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are bivalent, bispecific binding proteins that specifically bind to two different HIV-1 Env protein epitopes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.